National Reconstruction Fund Corporation invests $27 million in glaucoma treatment device maker
The National Reconstruction Fund Corporation will reportedly announce a $27 million stake in PolyActiva, a company commercialising an injectable device to treat glaucoma. According to The Australian Financial Review, the investment to be announced on Friday is alongside $13 million in new funding from Brandon Capital, and will support PolyActiva in moving to phase-two trials,…
